cyclic 1,n(2)-propanodeoxyguanosine has been researched along with acetaldehyde in 1 studies
Studies (cyclic 1,n(2)-propanodeoxyguanosine) | Trials (cyclic 1,n(2)-propanodeoxyguanosine) | Recent Studies (post-2010) (cyclic 1,n(2)-propanodeoxyguanosine) | Studies (acetaldehyde) | Trials (acetaldehyde) | Recent Studies (post-2010) (acetaldehyde) |
---|---|---|---|---|---|
7 | 0 | 1 | 6,226 | 77 | 1,268 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cai, H; Daniels, JS; Guengerich, FP; Marnett, LJ; Osheroff, N; Riggins, JN; VĂ©lez-Cruz, R | 1 |
1 other study(ies) available for cyclic 1,n(2)-propanodeoxyguanosine and acetaldehyde
Article | Year |
---|---|
Exocyclic DNA lesions stimulate DNA cleavage mediated by human topoisomerase II alpha in vitro and in cultured cells.
Topics: Acetaldehyde; Alkylating Agents; Antigens, Neoplasm; Cell Line, Tumor; Cell Survival; Deoxyguanosine; DNA Adducts; DNA Damage; DNA Repair; DNA Topoisomerases, Type II; DNA-Binding Proteins; Histone-Lysine N-Methyltransferase; Humans; Myeloid-Lymphoid Leukemia Protein; Proto-Oncogenes; Transcription Factors | 2005 |